From Financial Modeling Prep: 2025-04-15 09:00:00

In the latest financial report, Johnson & Johnson (NYSE:JNJ) showcased its strong market position with earnings per share (EPS) of $2.77, surpassing estimates and demonstrating growth from the previous year. The company’s revenue reached approximately $21.89 billion, exceeding expectations and leading to an increased sales forecast for 2025. Financial Health Indicators such as a debt-to-equity ratio of 0.51 and a current ratio of approximately 1.11 highlight the company’s solid financial position, making it an attractive option for investors.



Read more at Financial Modeling Prep:: Johnson & Johnson’s Impressive Financial Performan…